Pro-adrenomedullin as a Novel Biomarker for Predicting Infections and Response to Antimicrobials in Febrile Patients With Hematologic Malignancies | Zendy

Munirah Al Shuaibi | Zendy; Ramez Bahu | Zendy; AnneMarie Chaftari | Zendy; Iba Al Wohoush | Zendy; William Shomali | Zendy; Ying Jiang | Zendy; Labib Debiane | Zendy; Sammy Raad | Zendy; Joseph E. Jabbour | Zendy; Fady Al Akhrass | Zendy; Ray Hachem | Zendy; Issam Raad | Zendy

Open Access

Pro-adrenomedullin as a Novel Biomarker for Predicting Infections and Response to Antimicrobials in Febrile Patients With Hematologic Malignancies

Author(s) -

Munirah Al Shuaibi,

Ramez Bahu,

AnneMarie Chaftari,

Iba Al Wohoush,

William Shomali,

Ying Jiang,

Labib Debiane,

Sammy Raad,

Joseph E. Jabbour,

Fady Al Akhrass,

Ray Hachem,

Issam Raad

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis1029

Subject(s) - procalcitonin , medicine , adrenomedullin , biomarker , intensive care medicine , antimicrobial , immunology , oncology , sepsis , microbiology and biotechnology , biochemistry , chemistry , biology , receptor

Health professionals and researchers have become increasingly interested in biomarkers that help them in diagnosis of infections with recent growing attention to procalcitonin (PCT) and pro-adrenomedullin (proADM).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research